SCHEMBL4378384

SCHEMBL4378384

CC(C)(C)N(C(=O)O)c1ccc(CC(=O)Nc2ccc(Nc3cc(-c4cccc5c4oc4ccccc45)ncn3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 3/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 2/20 0.36
ROCK1 Q13464 1/20 0.36
FLT3 P36888 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
MAPT P10636 2/20 0.36
ADORA2A P29274 1/20 0.36
PIP4K2C Q8TBX8 1/20 0.36
CCNT1 O60563 3/20 0.35
CDK9 P50750 3/20 0.35
KDR P35968 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375735 0.92 CYP1A2 (0.41) RETCYP1A2CYP2D6LMNACYP3A4
SCHEMBL1243765 0.90 ALDH1A1 (0.43) CYP1A2CYP2D6LMNACYP3A4ROCK1
SCHEMBL1241945 0.88 CYP3A4 (0.41) CYP1A2CYP2D6LMNACYP3A4ROCK1
SCHEMBL1243835 0.86 RET (0.39) RETCYP1A2CYP2D6CYP3A4ROCK1
SCHEMBL4378388 0.86 GLS (0.41) RETCYP3A4ROCK1MAPTPIP4K2C
SCHEMBL1244511 0.86 RET (0.41) RETCYP1A2CYP2D6LMNACYP3A4
SCHEMBL1244631 0.86 CCNT1 (0.41) RETCYP3A4ROCK1TSHRMAPT
Trifluoroacetic Acid SCHEMBL1243757 0.85 RET (0.39) RETCYP1A2CYP2D6CYP3A4ROCK1
SCHEMBL4375143 0.85 PIP4K2C (0.43) CYP1A2CYP2D6LMNACYP3A4ALDH1A1
SCHEMBL16415729 0.84 CYP3A4 (0.41) CYP1A2CYP2D6LMNACYP3A4ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763526-B1 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AG (DE) 2009-06-24 EP claimed
CN-112472699-A Combination methods for improving the therapeutic benefit of bisantrene and derivatives 种族肿瘤学公司 2021-03-12 CN disclosed